Investment Summary

RoundTable Healthcare Management Invests In Deerland Probiotics & Enzymes

On June 20, 2017, private equity firm RoundTable Healthcare Management invested in consumer products company Deerland Probiotics & Enzymes

Investment Highlights
  • This is RoundTable Healthcare Management’s 4th transaction in the Consumer Products sector.
  • This is RoundTable Healthcare Management’s 21st transaction in the United States.
  • This is RoundTable Healthcare Management’s 1st transaction in Georgia.
Investment Fate
  • Deerland Probiotics & Enzymes was sold to a publicly-traded strategic buyer in 2021.

Investment Summary
Date 2017-06-20
Target Deerland Probiotics & Enzymes
Sector Consumer Products
Investor(s) RoundTable Healthcare Management
Deal Type Growth Capital
Advisor(s) Preti, Flaherty, Beliveau & Pachios
McCann FitzGerald (Legal)

Target

Deerland Probiotics & Enzymes

Kennesaw, Georgia, United States
website
Deerland Probiotics & Enzymes is a developer, formulator, and manufacturer of enzyme- and probiotic-based dietary supplements. Deerland specializes in customized product formulations and offers a line of clinically-studied branded ingredients, including its probiotic, DE111, which recently earned Non-GMO Project verification and Health Canada approval. The Company also offers multiple branded enzymes, including its innovative Glutalytic and ProHydrolase products. Deerland Enzymes was founded in 1990 and is based in Kennesaw, Georgia.

Search 192,723 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

RoundTable Healthcare Management

Lake Forest, Illinois, United States

Investor Investor Investor Investor Investor

website

Category Private Equity Firm
Founded 2001
PE ASSETS 2.9B USD
Size Large
Type Sector Focused
DESCRIPTION

RoundTable Healthcare Partners is a specialist private equity firm that targets equity and junior capital investments in the healthcare industry. Specific areas of interest include medical devices, medical products and disposables, specialty pharmaceuticals, medication delivery systems, specialty distribution, and outsourced healthcare services. RoundTable typically makes equity investments of approximately $5 to $50 million in platform companies with revenues ranging from $25 to $300 million. RoundTable will not invest in service-oriented provider segments (such as managed care companies, hospitals or nursing homes), internet or biotechnology companies, or start-up/venture situations. RoundTable was formed in 2001 and is based in Lake Forest, Illinois.

DEAL STATS #
Overall 22 of 27
Sector (Consumer Products) 4 of 6
Type (Growth Capital) 3 of 3
State (Georgia) 1 of 1
Country (United States) 21 of 26
Year (2017) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-08-03 Revision Skincare

Irving, Texas, United States

Revision Skincare LLC providess dermatologists, plastic surgeons, and medical spas with clinically-proven, high-performing skincare products. Using only premium quality ingredients, the Revision Skincare collection was formulated to provide targeted solutions for enhancing skin’s appearance and reducing signs of aging. Revision Skincare is based in Irving, Texas.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-01 Argon Medical Devices

Plano, Texas, United States

Argon Medical Devices, Inc. is a manufacturer and supplier of specialty single-use vascular interventional and pressure monitoring devices utilized in the cardiology, radiology and critical care market segments. Argon Medical Devices was founded in 1972 and is based in Plano, Texas.

Sell -
Mergr

Product

Company

Legal